Image
Billy W Loo, Jr, MD PhD FASTRO FACR
Professor - University Medical Line, Radiation Oncology - Radiation Therapy
Member, Bio-X
Member, Maternal & Child Health Research Institute (MCHRI)
Member, Stanford Cancer Institute
Member, Wu Tsai Neurosciences Institute
Residency: Stanford University Radiation Oncology Residency (2005) CA
Internship, Kaiser Permanente San Francisco Internal Medicine Residency, CA (2001)
Medical Education: University of California Davis School of Medicine (2000) CA
Board Certification: American Board of Radiology, Radiation Oncology (2006)
Ph.D., U.C. San Francisco, U.C. Berkeley, Bioengineering (2000)
A.B., U.C. Berkeley, Biophysics (1989)
Affiliation:
Billy W. Loo Jr., MD PhD is a Professor of Radiation Oncology, a member of the Stanford Cancer Institute, of the Molecular Imaging Program at Stanford (MIPS), and of Bio-X. He is a physician-scientist Radiation Oncologist and Bioengineer who directs the Thoracic Radiation Oncology Program and is Principal Investigator of the FLASH Sciences Lab @Stanford.
His clinical specialty is precision targeted radiotherapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR). Dr. Loo is a recognized expert in thoracic cancers serving on multiple national committees (including as writing member or vice-chair) that publish clinical guidelines on the treatment of lung cancer and other thoracic malignancies, particularly the National Comprehensive Cancer Network (NCCN).
His clinical research is in clinical trials and implementation of new treatment techniques for lung cancer, and development of new medical imaging methods for measuring organ function and predicting response to cancer treatment. He also has developed novel applications of SABR including treatment of pulmonary emphysema and cardiac arrhythmias.
Since conceiving of a fundamentally new approach to delivering ultra-rapid, ultra-precise cancer therapy, pluridirectional high-energy agile scanning electronic radiotherapy (PHASER), Dr. Loo's major laboratory research focus has been to co-lead a collaborative effort between Stanford Medicine and SLAC National Accelerator Laboratory to develop PHASER into a transformative and clinically practical technology. This program comprises both technology development and fundamental research on the radiobiology of extremely rapid FLASH therapy to optimize the biological therapeutic index.
Dr. Loo received his MD from University of California, Davis and his PhD in Bioengineering from University of California, San Francisco and Berkeley. He completed his Radiation Oncology residency training at Stanford University. He is certified by the American Board of Radiology in Radiation Oncology, and is a Fellow of the American Society for Radiation Oncology (ASTRO) and a Fellow of the American College of Radiology (ACR).
His clinical specialty is precision targeted radiotherapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR). Dr. Loo is a recognized expert in thoracic cancers serving on multiple national committees (including as writing member or vice-chair) that publish clinical guidelines on the treatment of lung cancer and other thoracic malignancies, particularly the National Comprehensive Cancer Network (NCCN).
His clinical research is in clinical trials and implementation of new treatment techniques for lung cancer, and development of new medical imaging methods for measuring organ function and predicting response to cancer treatment. He also has developed novel applications of SABR including treatment of pulmonary emphysema and cardiac arrhythmias.
Since conceiving of a fundamentally new approach to delivering ultra-rapid, ultra-precise cancer therapy, pluridirectional high-energy agile scanning electronic radiotherapy (PHASER), Dr. Loo's major laboratory research focus has been to co-lead a collaborative effort between Stanford Medicine and SLAC National Accelerator Laboratory to develop PHASER into a transformative and clinically practical technology. This program comprises both technology development and fundamental research on the radiobiology of extremely rapid FLASH therapy to optimize the biological therapeutic index.
Dr. Loo received his MD from University of California, Davis and his PhD in Bioengineering from University of California, San Francisco and Berkeley. He completed his Radiation Oncology residency training at Stanford University. He is certified by the American Board of Radiology in Radiation Oncology, and is a Fellow of the American Society for Radiation Oncology (ASTRO) and a Fellow of the American College of Radiology (ACR).